Finance

Lists
Q3 2026 earnings • released • EPS beat +१६.६७% • Revenue miss -०.३७%
See results
OSUR:NASDAQ
OraSure Technologies Inc
US$ ३.३७
-४.५३%
(-०.१६) 1D
नोभेम्बर १०, १२:५९:३३ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OSUR...
Open
US$ ३.४७
High
US$ ३.५६
Low
US$ ३.३१
Mkt. cap
२३.२४ करोड
Avg. vol.
६.०२ लाख
Volume
३.२० लाख
52-wk high
US$ ४.५८
52-wk low
US$ २.०८
EPS
-US$ ०.६९
Beta
१.०८
Shares outstanding
६.९० करोड
No. of employees
५००
Open
US$ ३.४७
High
US$ ३.५६
Low
US$ ३.३१
Mkt. cap
२३.२४ करोड
Avg. vol.
६.०२ लाख
Volume
३.२० लाख
52-wk high
US$ ४.५८
52-wk low
US$ २.०८
EPS
-US$ ०.६९
Beta
१.०८
Shares outstanding
६.९० करोड
No. of employees
५००
News stories
From web sources and news partners
Sickle Cell Disease News
Sickle Cell Disease News
·
१ घण्टा पहिले
Diagnostics company joins global coalition to boost sickle cell care
GuruFocus
GuruFocus
·
९ घण्टा पहिले
OraSure Technologies (OSUR) Reports Q3 Revenue Growth and FDA EU
TradingView
TradingView
·
१६ घण्टा पहिले
OraSure Technologies Q3 Earnings Call Highlights
Benzinga
Benzinga
·
१९ घण्टा पहिले
OraSure Technologies Q3 2026 Earnings Call Transcript
Profile
OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test. Wikipedia
About OraSure Technologies Inc
CEOCarrie Eglinton Manner
Employees५००
Founded१९८७ डिसेम्बर ११
Headquartersबेतलेहेम, पेन्सिलभेनिया, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Analyst ratings
Based on 1 analyst giving stock ratings to OSUR in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for OSUR in the last 3 months
Highest
Current US$ ३.३७
US$ ७.०० (+१०७.७२%)
Average
US$ ७.०० (+१०७.७२%)
Lowest
US$ ७.०० (+१०७.७२%)
Analyst
Recommendation
Action
Price target
Projected
Date
William Bonello
Craig-Hallum
Buy
Initiated
US$ ७.००
+१०७.७%
10/23/2026
Last report
Just released
Today, ००:००
Fiscal period
Q3 2026
-US$ ०.१५ / -US$ ०.१८
+१६.६७%beat
Revenue / Est. (USD)
३.०९ करोड / ३.१० करोड
-०.३७%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२.७१ करोड
२.६८ करोड
२.७९ करोड
३.०६ करोड
Cost of goods sold
१.५३ करोड
१.५८ करोड
१.६१ करोड
१.७३ करोड
Cost of revenue
१.५३ करोड
१.५८ करोड
१.६१ करोड
१.७३ करोड
Research and development expenses
१.०१ करोड
१.१४ करोड
१.३४ करोड
९४.३७ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.७४ करोड
१.५९ करोड
२.०४ करोड
२.१० करोड
Operating expense
२.७५ करोड
२.७३ करोड
३.३८ करोड
३.०५ करोड
Total operating expenses
४.२८ करोड
४.३१ करोड
४.९८ करोड
४.७८ करोड
Operating income
-१.५७ करोड
-१.६४ करोड
-२.१९ करोड
-१.७२ करोड
Other non operating income
२१.९९ लाख
१८.७१ लाख
१.२८ लाख
२.७२ लाख
EBT including unusual items
-१.३७ करोड
-१.९१ करोड
-२.२८ करोड
६३.०४ लाख
EBT excluding unusual items
-१.३३ करोड
-१.५३ करोड
-२.१४ करोड
-१.६३ करोड
Income tax expense
४७.०० हजार
२.१० लाख
-४.३२ लाख
५५.०० हजार
Effective tax rate
-०.३४%
-१.१०%
१.८९%
०.८७%
Other operating expenses
-
-
-
-
Net income
-१.३७ करोड
-१.९३ करोड
-२.२४ करोड
६२.४९ लाख
Net profit margin
-५०.६३%
-७२.०६%
-८०.१३%
२०.४०%
Earnings per share
-०.१३
-०.१९
-०.२४
-०.२०
Interest and investment income
-
-
१२.२० लाख
१२.०५ लाख
Interest expense
-
-
-
-
Net interest expenses
-
-
१२.२० लाख
१२.०५ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.३३ करोड
-१.३९ करोड
-१.९६ करोड
-१.४८ करोड
Gain or loss from assets sale
-२.१३ लाख
२.६८ लाख
-
-२०.०० हजार
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू